Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Reviews
Customer Reviews
Application Protocols
No tested applications or protocols are provided in the Product Data for this item.
General starting points for small molecules in discovery workflows
Stock preparation: Dissolve in anhydrous DMSO to 10–50 mM; vortex and, if needed, sonicate briefly. Filter through 0.2 µm PTFE prior to critical assays.
Plate handling: Store working plates at −20 °C to reduce freeze–thaw of master stocks; seal to limit DMSO uptake of water.
Assay dilution: Titrate in half-log or log dilutions to define a full concentration–response. Maintain constant final DMSO across wells.
Controls: Include vehicle controls, known positive controls (assay-specific), and interference controls (detergent for aggregation, redox quenchers for ROS-prone assays as appropriate).
These are general recommendations and not item-specific validated procedures.
Biological Roles
No biological roles, targets, or pathways are provided for WAY-325911 in the Product Data. Accordingly, no functional claims are made for this compound.
General guidance for small-molecule research compounds
Treat as an uncharacterized research article unless independently verified. Confirm identity and purity prior to mechanistic studies.
If using in cells or biochemical assays, establish a concentration–response curve and evaluate potential assay interferences (e.g., autofluorescence, quenching, redox activity).
Assess basic liabilities: cytotoxicity counterscreens, colloidal aggregation controls, and redox cycling assays where relevant.
For mechanism-of-action studies, complement phenotypic results with orthogonal assays (e.g., thermal shift, CETSA, target engagement biosensors) once a putative target is hypothesized from external literature.
Research use only: No clinical, diagnostic, or veterinary applications are claimed or supported.
Buffer Applications
WAY-325911 is a small organic compound and is not a buffering agent. No buffer system usage is indicated in the Product Data.
If biological assays require aqueous delivery, prepare concentrated stocks (commonly in DMSO) and dilute into the chosen buffer (PBS, HEPES, TRIS, etc.) while keeping final cosolvent low (typically 0.1–1% v/v) and within assay tolerance.
Verify compound stability in the selected buffer over the assay timescale (hydrolysis, oxidation, precipitation) and adjust pH/antioxidants only if compatible and justified by stability data.
Green Alternatives
While WAY-325911 itself is a fixed substance, greener choices can be made for its handling and formulation. No item-specific solvent constraints are provided; consider the following general alternatives when preparing solutions or running analytics.
Greener solvent choices (general)
Replace DMF/NMP with safer polar aprotics where feasible: Cyrene (dihydrolevoglucosenone), propylene carbonate, or ethyl lactate for certain dissolution or reaction contexts.
Prefer ethanol or isopropanol over methanol when comparable performance is acceptable.
For extractions or preparative work, consider ethyl acetate or methyl tert‑butyl ether (MTBE) instead of dichloromethane/chloroform when resolution permits.
DMSO: broadly acceptable in micro-quantities for bioassays; high boiling point and hygroscopicity require care.
Cyrene/propylene carbonate: improved EHS profiles; viscosity and limited miscibility can be trade-offs.
Operational practices
Use microscale assays to minimize solvent volumes.
Apply closed-vial handling and cold traps to reduce VOC emissions.
Document final % solvent in biological assays; keep within validated low v/v to reduce environmental and biological impact.
Pharmaceutical Uses
No pharmaceutical or excipient uses are provided in the Product Data, and none are implied.
Regulatory status: Not specified; this material is supplied strictly for research use only.
Formulation context (general research): If used in preclinical assay systems, common vehicles include DMSO stocks diluted into aqueous buffers or, for in vivo exploratory research in non-clinical models, co-solvent systems such as PEG‑400/saline or Captisol are sometimes used—such usage requires institution-specific approvals and falls outside this catalog listing. No recommendations are made for clinical formulation.
Pharmacopeial monographs: None indicated.
Note: This product is not intended for human or veterinary administration and should not be incorporated into therapeutic or diagnostic products.
Physical Properties
Item-specific physicochemical parameters are not provided in the Product Data.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Melting point: Not specified for this item; refer to CoA/Spec Sheet.
Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
Density: Not specified for this item; refer to CoA/Spec Sheet.
Solubility: Not specified for this item; refer to CoA/Spec Sheet.
LogP/logD, pKa, refractive index: Not specified for this item; refer to CoA/Spec Sheet.
Practical screening (general guidance for small molecules)
Solubility panel: DMSO (first choice), DMF, acetone, acetonitrile, methanol, ethanol; for aqueous work, prepare DMSO stock and dilute into PBS, HBSS, or assay buffer keeping final DMSO ≤0.1–1% v/v as assay-tolerated.
If solid: perform a micro-scale thermogram (DSC) or melting range check to inform handling.
Conduct a quick UV–Vis scan (200–400 nm) of a dilute solution to assess potential interference in UV-based assays.
If hygroscopic or light-sensitive behavior is suspected, handle in a desiccator and protect from light; verify with CoA.
Note: Where literature values are needed, consult trusted databases using CAS 868970-94-9 or CID 4434586. Any values sourced externally should be cited as “literature” and not assumed as this item’s specification.
Quality & Grades
Item-specific quality details are not provided in the Product Data.
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Stabilizers/antioxidants: Not specified for this item; refer to CoA/Spec Sheet.
Residual solvents/metals, water/peroxide content, and chromatographic purity windows: Not specified for this item; refer to CoA/Spec Sheet.
Guidance on interpreting grades (general)
Screening/library compounds are commonly supplied at ≥95% area by HPLC/UPLC unless otherwise noted; however, do not assume—use the CoA as the definitive source for this lot.
If UV transparency or LC–MS compatibility is critical, request chromatograms and impurity profiles. For structure–activity work, confirm batch-to-batch consistency by HPLC area% and HRMS.
If the compound is chiral, ask for enantiomeric excess (ee) or diastereomeric ratio (dr). If a salt form exists, verify counter‑ion stoichiometry and residual inorganic content.
What is specific to this item
The catalog entry lists the compound as a small molecule in a screening library category; no additional grade or purity is claimed in the Product Data. Rely on the CoA for assay-fitness and release specifications for SKU W417145.
Reaction & Applications
Manufacturer Applications: Not specified in the Product Data for WAY-325911 beyond inclusion in a small-molecule/compound library. The following outlines typical uses of such compounds in research settings.
Research applications (general)
Probe discovery and SAR: Use as a starting point for biochemical or cell-based screening to define preliminary structure–activity relationships.
Assay development: Serve as a test article for evaluating assay window, dynamic range, and interferences (fluorescence, absorbance, aggregation).
Reference control: If literature reports emerge for this CAS/CID, it may function as a comparator compound within a chemical series. Verify identity and activity independently.
Analytical considerations
Purity check by LC–MS/UPLC before screening; track stability under assay conditions (DMSO at room temperature vs incubator, light exposure).
Test for colloidal aggregation using detergent controls or DLS where applicable to reduce false positives.
Synthesis and derivatization
If structure is available from external databases, medicinal chemistry teams may explore analog synthesis (scaffold hopping, isosteres, polar surface area tuning) to optimize potency/ADME. Without item structural data, consult CAS/CID sources before planning derivatives.
Important: No target, pathway, or mechanism is claimed or implied for this item in the Product Data. All use is for research only.
Reaction Conditions
No reaction conditions are provided for WAY-325911, and without a disclosed structure, prescriptive chemistry cannot be given.
General guidance for handling in reactions (if derivatization is planned after obtaining structure)
Solvent system: Choose based on functional groups (e.g., polar aprotic for cross-couplings; alcohols or esters for nucleophilic substitutions where suitable).
Temperature: Begin with ambient trials; escalate as needed while monitoring for decomposition by LC–MS. Use inert atmosphere if oxidation-sensitive motifs are present.
Catalysts/additives: Select in line with the intended transformation (e.g., Pd catalysts for C–C couplings; boron/acid catalysts for reductive amination). Avoid heavy-metal residues if the product is destined for bioassays; include scavenging steps.
Workup/purification: Favor minimal aqueous workups to preserve sensitive functionalities; use reverse-phase prep LC when normal-phase chromatography causes degradation.
All values above are general literature guidance and not item-specific specifications. Consult the CoA and establish small-scale feasibility before scale-up.
Safety & Handling
Safety data specific to this item are not provided in the Product Data. Always consult the SDS for authoritative guidance.
GHS/Classification (item-specific)
Signal word: Not specified for this item; refer to SDS.
H-statements: Not specified for this item; refer to SDS.
Pictograms: Not specified for this item; refer to SDS.
General laboratory precautions for small organic molecules
PPE: lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Avoid inhalation, ingestion, and skin contact.
Engineering controls: handle powders in a fume hood or ventilated enclosure; minimize dust/aerosols.
First aid (overview): in case of skin/eye contact, rinse with water for ≥15 min; if inhaled, move to fresh air; if swallowed, do not induce vomiting—seek medical attention. Follow site SOPs.
Spill/cleanup: contain and collect with inert absorbent; avoid discharge to drains; dispose per local regulations.
Fire-fighting: many organics are combustible; use CO2, dry chemical, or foam; firefighters wear SCBA.
Special risks
Unknown sensitization or toxicity profile: adopt conservative exposure controls.
If compound contains latent hazardous motifs (e.g., nitroso, azide), additional precautions may apply—confirm via SDS/CoA.
Research use only: Not for human or veterinary use.
Solvent Selection
No item-specific solubility data are provided. The following guidance reflects best practice for dissolving small organic molecules for analytical or biological assays.
Primary stock solvent: DMSO is recommended as the first-line solvent due to broad solvating power and assay compatibility at low v/v.
Secondary solvents: DMF, acetonitrile, methanol, ethanol; for particularly lipophilic materials, consider 1-methyl-2-pyrrolidone (NMP) or PEG‑400 for higher concentration stocks.
Aqueous work: Prepare a concentrated DMSO stock (e.g., 10–50 mM) and dilute into buffered media (PBS, HBSS, assay buffer) ensuring final cosolvent within tolerance (typically 0.1–1% v/v).
Surfactant aids: For difficult cases, 0.01–0.05% nonionic surfactant (e.g., Tween 80) can improve dispersion in biological buffers—confirm assay compatibility first.
Filtration: If particulate persists, pass through 0.2 µm PTFE or PVDF filters; avoid nylon when strong H-bond donors/acceptors may bind.
Selection tips and comparisons (general)
DMSO vs DMF: DMSO preferred for bioassays (lower toxicity at low % and better miscibility control). DMF may offer slightly different solvation but is less favored biologically.
MeOH/EtOH: Useful for analytical calibration curves; can precipitate in aqueous dilution more readily than DMSO.
Acetonitrile: Excellent for LC-ready solutions; lower viscosity than DMSO; volatility aids removal but can limit high-concentration stocks.
Storage & Reconstitution
Storage conditions (item-specific)
Storage: Room temperature (as provided in Product Data).
Shipped in: Not specified for this item; refer to CoA/Spec Sheet.
Container/closure: Not specified for this item; refer to CoA/Spec Sheet.
General best practices
Protect from moisture and light until more is known about stability; store in a desiccator or with desiccant in an amber vial.
If long-term retention is planned, consider aliquoting solid or stock solutions to avoid repeated opening and freeze–thaw.
Reconstitution (general guidance)
Prepare a concentrated DMSO stock (e.g., 10–50 mM). If insoluble, try DMF or acetonitrile, then dilute into assay buffer keeping final solvent within acceptable limits.
Warm gently to room temperature and vortex/sonicate briefly to aid dissolution; avoid prolonged heating.
Filter through 0.2 µm PTFE prior to sensitive assays. Record solvent lot, concentration, and date of preparation.
Stability notes
No item-specific stability data are provided. Verify short-term and in-assay stability by LC–MS or HPLC. For aqueous use, assess for precipitation over the assay timeframe.
Research Use Note: For research use only.
Structure & Identity
Brief overview: WAY-325911 is listed as a small-molecule screening compound. Item-specific structural descriptors are not provided in the Product Data.
CAS: 868970-94-9 (item-specific)
PubChem CID: 4434586 (item-specific)
InChIKey: 331677 (item-specific; note: not in standard 27-character format; verify on CoA/SDS or databases)
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Structural features
Item-specific structural features (rings, heteroatoms, stereochemistry) cannot be described without a provided structure. Consult the CoA/Spec Sheet or trusted databases using the CAS or CID above.
Match spectral data against supplier CoA spectra. Where available, cross-check calculated exact mass and isotopic pattern against HRMS data.
For screening compounds, orthogonal ID checks (LC–MS plus NMR) are prudent before critical studies.
Synthetic Utility
The Product Data do not provide a structure, functional groups, or reactivity profile; therefore, no item-specific synthetic roles can be asserted.
General considerations if structure is obtained from CoA/literature
Functional-group mapping enables forward planning of selective transformations (e.g., amide coupling, Suzuki–Miyaura cross-coupling, reductive amination) to build analogs for SAR.
Protecting-group strategy: If multiple nucleophilic/acidic sites exist, map pKa values to choose orthogonal protections.
Late-stage diversification: Microscale parallel chemistry (SNAr, C–H functionalization, sulfonylation) can rapidly explore vectors without resynthesis of the core.
Analytical control
Use UPLC with MS and PDA to monitor reactions; collect mass balance on impurities relevant to biological activity.
Confirm absolute configuration where stereochemistry is relevant (VCD, ECD, X-ray with Cu Kα, or chiral HPLC comparisons).
Without the structure, treat WAY-325911 as a final test article rather than a reagent. Obtain the structural record via CAS 868970-94-9 or CID 4434586 before planning any synthetic campaigns.
Target Specificity
No target, pathway, or binding specificity is provided in the Product Data for WAY-325911. Accordingly, no claims are made regarding mechanism of action, selectivity, or potency.
If external literature assigns a target to CAS 868970-94-9 or CID 4434586, independently confirm with orthogonal assays (binding and functional readouts) and verify compound identity/purity from the supplied lot.
Record and report any in-house observed activity with full methodological transparency (assay format, controls, concentration range, solvent %, and statistics) to avoid overinterpretation of preliminary screening signals.
Frequently Asked Questions
What is the purity of this product?
This product is supplied at ≥95% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 868970-94-9, the molecular formula is C16H13F2N3O, and the molecular weight is 301.29 g/mol. InChIKey SBPFCQVBMLOALK-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.